Cargando…
Manual of Commercial Methods in Clinical Microbiology.
The Manual of Commercial Methods in Clinical Microbiology 2nd Edition, International Edition reviews in detail the current state of the art in each of the disciplines of clinical microbiology, and reviews the sensitivities, specificities and predictive values, and subsequently the effectiveness, of...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Wiley,
2016.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Title Page; Table of Contents; Important Notice; Preface to the Second Edition; Foreword; Acknowledgments; Rising Sun Chair; Contributors; CHAPTER 1: Role of the US Food and Drug Administration in the Regulation of Clinical Microbiology Devices; 1.1 Historical overview of in vitro diagnostics; 1.2 Current microbiology device review regulatory pathways: practical considerations; 1.3 Assay performance characteristics: "Statistics 101" for diagnostic device developers[1]; 1.4 Common issues with new FDA submissions; Appendix: web sites; References.
- CHAPTER 2: Commercial Blood Culture Systems and Methods2.1 Manual blood cultures; 2.2 Automated blood culture systems; 2.3 Molecular and other methods; 2.4 Future directions; References; CHAPTER 3: Rapid Devices and Instruments for the Identification of Aerobic Bacteria; 3.1 Introduction; 3.2 Major methods currently available; 3.3 Commercial systems for identification of Gram-positive organisms; 3.4 Commercial systems for identification of Gram-negative organisms; 3.5 Commercial methods for identification of microorganisms directly in blood culture bottles.
- 3.6 Commercial molecular methods for identification of bacteria isolated in culture3.7 Emerging technologies for the identification of organisms: mass spectrometry; References; CHAPTER 4: Rapid Devices and Instruments for the Identification of Anaerobic Bacteria; 4.1 Introduction and clinical considerations; 4.2 Steps in the diagnosis of anaerobic bacterial infections; 4.3 Commercial kit requiring 24 h of anaerobic incubation; 4.4 Commercial enzyme kits for identification after four hours ofaerobic incubation; 4.5 Identification by gene sequencing; 4.6 Identification by chemical methods.
- 4.7 Immunodiagnostic and molecular methods for diagnosis of Clostridium difficile infectionReferences; CHAPTER 5: Rapid Antigen Devices and Instruments for the Detection and Identification of Viruses; 5.1 Influenza viruses; 5.2 Respiratory syncytial virus; 5.3 Immunofluorescence staining of respiratory viruses; 5.4 Herpes simplex virus, varicella zoster virus, cytomegalovirus; 5.5 Gastrointestinal viruses; References; CHAPTER 6: Molecular Tests for the Identification of Viruses; 6.1 Introduction; 6.2 Respiratory viral infections; 6.3 Enteric viruses; 6.4 Enterovirus and parechovirus.
- 6.5 Herpesviruses6.6 Viral infections associated with transplantation; 6.7 Implementation and additional considerations; References; CHAPTER 7: Viral Hepatitis; 7.1 Introduction/background; 7.2 Clinical manifestations, epidemiology, and diagnostic considerations by virus; 7.3 Commercial methods; 7.4 Summary; References; CHAPTER 8: Human Papillomaviruses; 8.1 Background; 8.2 Commercial assays; 8.3 Current challenges and future directions; References; CHAPTER 9: Human Immunodeficiency Virus; 9.1 Introduction; 9.2 Markers of HIV infection; 9.3 HIV screening; 9.4 Laboratory-based immunoassays.